Aug 15 (Reuters) - ContextVision AB COVI.OL :
* REG-CONTEXTVISION - SECOND QUARTER SAW COMMERCIAL RELEASE
OF
FIRST AI-BASED PRODUCT, ALTUMIRA™, DIGITAL PATHOLOGY ON TRACK
AND RECORD SALES
* SALES CONTINUED TO GROW IN Q2 REACHING 23,1 MSEK, HIGHEST
EVER
SALES IN A Q2 FOR COMPANY
* SALES IN ASIA GREW NINE PERCENT COMPARED TO SAME QUARTER
LAST
YEAR
* Q2 OPERATING PROFIT SEK 5.4 MILLION VERSUS LOSS SEK 1.2
MILLION
YEAR AGO
* OPERATING RESULT WAS POSITIVE 5,4 MSEK, MAINLY DUE TO
HIGHER
CAPITALIZATION FOR PRODUCT DEVELOPMENT BUT ALSO SUPPORTED BY
STRONG SALES PERFORMANCE
Source text for Eikon: ID:nGNEc7qYJ5
Further company coverage: COVI.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))